Abbott Laboratories (ABT)

Healthcare

$96.97

LAST CLOSE · OCT 1

Abbott Laboratories (ABT) is a Healthcare stock tracked by StreetAlpha. It last closed at $96.97 on Oct 1. ABT reports earnings on Wed, Oct 21, 2026. The average 12-month price target from 10 analysts is $123.30 (+27.2% from the last close), with a high of $135.00 and a low of $112.00. Analyst consensus is Strong Buy, based on the latest ratings from 10 firms (10 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in ABT, 0% of them bullish and 100% bearish. In the past 30 days there were 17 dark pool prints totaling $21.0M, the largest $5.5M.

FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily Cboe FLEX report for unusually large, long-dated positions.

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABT is in one of them and how their past ABT trades turned out.

StreetAlpha hasn't covered ABT in an article yet. Here's the latest on the wider market.